Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34817587.
- Also identified by DOI 10.1001/jamanetworkopen.2021.36030 and PMC identifier 8613594.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France.
Medical subject headings
- Antibodies, Viral
- COVID-19
- COVID-19 Vaccines
- Organ Transplantation
- SARS-CoV-2
- Transplant Recipients